Effect of hydrophobic and hydrophilic additives on sol-gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogel

Colloid and Polymer Science

Volumn 289, Issue 14, 2011, Pages 1553-1562

  Mishra, Gyan P ^a   Tamboli, Viral ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Drug release; Hydrogel; Polymeric additive; Sol gel transition

Indexed keywords

CAPROLACTONE; CRITICAL GEL CONCENTRATION; CULTURE CELLS; DRUG RELEASE; HYDROGEL MATRIX; HYDROPHILIC AND HYDROPHOBIC; HYDROPHOBIC AND HYDROPHILIC; POLYMERIC ADDITIVES; RELEASE BEHAVIORS; RELEASE KINETICS; RELEASE PROFILES; SOL-GEL TRANSITION; SOL-GEL TRANSITIONS; STATISTICALLY SIGNIFICANT DIFFERENCE; THERMO-SENSITIVE HYDROGEL; TIMOLOL MALEATE; TRIBLOCK POLYMERS;

ADDITIVES; CELL CULTURE; ETHYLENE; GELS; GLYCOLS; HYDROPHILICITY; HYDROPHOBICITY; POLYCAPROLACTONE; POLYETHYLENE GLYCOLS; POLYMERS; SOL-GEL PROCESS; SOL-GELS; SOLS;

HYDROGELS;

DRUG ADDITIVE; MACROGOL; POLYCAPROLACTONE; POLYVINYL ALCOHOL; TIMOLOL MALEATE;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; DRUG RELEASE; GEL PERMEATION CHROMATOGRAPHY; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; SCANNING ELECTRON MICROSCOPY; SOL GEL TRANSITION;

EID: 80052502405     PISSN: 0303402X     EISSN: 14351536     Source Type: Journal    
DOI: 10.1007/s00396-011-2476-y     Document Type: Article

References (35)

1. L Klouda AG Mikos 2008 Thermoresponsive hydrogels in biomedical applications Eur J Pharm Biopharm 68 1 34 45 10.1016/j.ejpb.2007.02.025 10.1016/j.ejpb.2007.02.025 1:CAS:528:DC%2BD2sXhsVSgtbrP (Pubitemid 350181413)
2. Garripelli VK, Kim JK, Namgung R, Kim WJ, Repka MA, Jo S A novel thermosensitive polymer with pH-dependent degradation for drug delivery. Acta Biomater 6(2):477-485. doi: 10.1016/j.actbio.2009.07.005
3. DP Huynh MK Nguyen BS Pi MS Kim SY Chae KC Lee BS Kim SW Kim DS Lee 2008 Functionalized injectable hydrogels for controlled insulin delivery Biomaterials 29 16 2527 2534 10.1016/j.biomaterials.2008.02.016 10.1016/j.biomaterials.2008. 02.016 1:CAS:528:DC%2BD1cXjvFOgurw%3D
4. DQ Wu CC Chu 2008 Biodegradable hydrophobic-hydrophilic hybrid hydrogels: swelling behavior and controlled drug release J Biomater Sci Polym Ed 19 4 411 429 10.1163/156856208783719536 10.1163/156856208783719536 1:CAS:528: DC%2BD1cXkvVyqs7s%3D (Pubitemid 351311661)
5. Zhang Y, Wu X, Han Y, Mo F, Duan Y, Li S Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels. Int J Pharm 386(1-2):15-22. doi: 10.1016/j.ijpharm.2009.10.045
6. Soares JS, Zunino P A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks. Biomaterials 31(11):3032-3042. doi: 10.1016/j.biomaterials.2010.01.008
7. F Li S Li AE Ghzaoui H Nouailhas R Zhuo 2007 Synthesis and gelation properties of PEG-PLA-PEG triblock copolymers obtained by coupling monohydroxylated PEG-PLA with adipoyl chloride Langmuir 23 5 2778 2783 10.1021/la0629025 10.1021/la0629025 1:CAS:528:DC%2BD2sXns1yjuw%3D%3D (Pubitemid 46383700)
8. B Jeong YH Bae SW Kim 2000 Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers J Control Release 63 1-2 155 163 10.1016/S0168-3659(99)00194-7 1:CAS:528:DC%2BD3cXks1Ggtw%3D%3D (Pubitemid 30046951)
9. MS Kim KS Seo G Khang SH Cho HB Lee 2004 Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials J Biomed Mater Res A 70 1 154 158 10.1002/jbm.a.30049 10.1002/jbm.a.30049 (Pubitemid 38849823)
10. P Kan XZ Lin MF Hsieh KY Chang 2005 Thermogelling emulsions for vascular embolization and sustained release of drugs J Biomed Mater Res B Appl Biomater 75 1 185 192 10.1002/jbm.b.30286 (Pubitemid 41395759)
11. Kang YM, Lee SH, Lee JY, Son JS, Kim BS, Lee B, Chun HJ, Min BH, Kim JH, Kim MS A biodegradable, injectable, gel system based on MPEG-b-(PCL-ran-PLLA) diblock copolymers with an adjustable therapeutic window. Biomaterials 31(9):2453-2460. doi: 10.1016/j.biomaterials.2009.11.115
12. X Wei C Gong M Gou S Fu Q Guo S Shi F Luo G Guo L Qiu Z Qian 2009 Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system Int J Pharm 381 1 1 18 10.1016/j.ijpharm.2009.07.033 10.1016/j.ijpharm.2009.07.033 1:CAS:528:DC%2BD1MXhtFOkurrM
13. M Qiao D Chen X Ma Y Liu 2005 Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels Int J Pharm 294 1-2 103 112 10.1016/j.ijpharm.2005.01.017 10.1016/j.ijpharm.2005. 01.017 1:CAS:528:DC%2BD2MXivFKktbc%3D (Pubitemid 40462325)
14. S Chen R Pieper DC Webster J Singh 2005 Triblock copolymers: synthesis, characterization, and delivery of a model protein Int J Pharm 288 2 207 218 10.1016/j.ijpharm.2004.09.026 10.1016/j.ijpharm.2004.09.026 1:CAS:528: DC%2BD2cXhtFGhurrP (Pubitemid 40038573)
15. N Mohan PD Nair 2008 Polyvinyl alcohol-poly(caprolactone) semi IPN scaffold with implication for cartilage tissue engineering J Biomed Mater Res B Appl Biomater 84 2 584 594 10.1002/jbm.b.30906
16. D Rohner DW Hutmacher TK Cheng M Oberholzer B Hammer 2003 In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig J Biomed Mater Res B Appl Biomater 66 2 574 580 10.1002/jbm.b.10037 10.1002/jbm.b.10037 (Pubitemid 37517131)
17. Z Jiang J Hao Y You Y Liu Z Wang X Deng 2008 Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)-poly(epsilon-caprolactone- co-glycolide)-poly(ethylene glycol) aqueous solutions J Biomed Mater Res A 87 1 45 51 10.1002/jbm.a.31699
18. DS Jones DW McLaughlin CP McCoy SP Gorman 2005 Physicochemical characterisation and biological evaluation of hydrogel-poly(epsilon- caprolactone) interpenetrating polymer networks as novel urinary biomaterials Biomaterials 26 14 1761 1770 10.1016/j.biomaterials.2004.06.002 10.1016/j.biomaterials.2004.06.002 1:CAS:528:DC%2BD2cXhtVCiurzO (Pubitemid 39575319)
19. JW Lee F Hua DS Lee 2001 Thermoreversible gelation of biodegradable poly(epsilon-caprolactone) and poly(ethylene glycol) multiblock copolymers in aqueous solutions J Control Release 73 2-3 315 327 10.1016/S0168-3659(01)00297-8 1:CAS:528:DC%2BD3MXksVSqurY%3D (Pubitemid 32539259)
20. Zhao S, Cao M, Li H, Li L, Xu W Synthesis and characterization of thermo-sensitive semi-IPN hydrogels based on poly(ethylene glycol)-co- poly(epsilon-caprolactone) macromer, N-isopropylacrylamide, and sodium alginate. Carbohydr Res 345(3):425-431. doi: 10.1016/j.carres.2009.11.014
21. MJ Hwang JM Suh YH Bae SW Kim B Jeong 2005 Caprolactonic poloxamer analog: PEG-PCL-PEG Biomacromolecules 6 2 885 890 10.1021/bm049347a 10.1021/bm049347a 1:CAS:528:DC%2BD2MXis12isg%3D%3D (Pubitemid 40467832)
22. TJ Zimmerman HE Kaufman 1977 Timolol, dose response and duration of action Arch Ophthalmol 95 4 605 607 1:CAS:528:DyaE2sXkslymt7w%3D (Pubitemid 8263099)
23. TJ Zimmerman HE Kaufman 1977 Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma Arch Ophthalmol 95 4 601 604 1:CAS:528: DyaE2sXkslymt78%3D (Pubitemid 8263098)
24. Peeters A, Schouten JS, Severens JL, Hendrikse F, Prins MH, Webers CA Latanoprost versus timolol as first choice therapy in patients with ocular hypertensionA cost-effectiveness analysis. Acta Ophthalmol. doi: 10.1111/j.1755-3768.2009.01857.x
25. WP Munroe JP Rindone RM Kershner 1985 Systemic side effects associated with the ophthalmic administration of timolol Drug Intell Clin Pharm 19 2 85 89 1:STN:280:DyaL2M7is1Crsg%3D%3D (Pubitemid 15160591)
26. HI Cheong J Johnson M Cormier K Hosseini 2008 In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pigment epithelial cell lines: comparison with epidermal keratinocytes and dermal fibroblasts Toxicol In Vitro 22 4 1070 1076 10.1016/j.tiv.2008.01.013 10.1016/j.tiv.2008.01. 013 1:CAS:528:DC%2BD1cXkvFWgsrc%3D
27. CY Gong PW Dong S Shi SZ Fu JL Yang G Guo X Zhao YQ Wei ZY Qian 2009 Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study J Pharm Sci 98 10 3707 3717 10.1002/jps.21694 10.1002/jps.21694 1:CAS:528:DC%2BD1MXhtVKhsr3P
28. DP Huynh GJ Im SY Chae KC Lee DS Lee 2009 Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel J Control Release 137 1 20 24 10.1016/j.jconrel.2009.02.021 10.1016/j.jconrel.2009.02.021 1:CAS:528:DC%2BD1MXmvVKqsL4%3D
29. SW Kim YH Bae T Okano 1992 Hydrogels: swelling, drug loading, and release Pharm Res 9 3 283 290 10.1023/A:1015887213431 1:CAS:528:DyaK38XitVSqs7Y%3D
30. Henke M, Brandl F, Goepferich AM, Tessmar JK Size-dependent release of fluorescent macromolecules and nanoparticles from radically cross-linked hydrogels. Eur J Pharm Biopharm 74(2):184-192. doi: 10.1016/j.ejpb.2009.08.011
31. K Makino J Hiyoshi H Ohshima 2001 Effects of thermosensitivity of poly (N-isopropylacrylamide) hydrogel upon the duration of a lag phase at the beginning of drug release from the hydrogel Colloids Surf B Biointerfaces 20 4 341 346 10.1016/S0927-7765(00)00201-0 1:CAS:528:DC%2BD3MXpt12qtA%3D%3D (Pubitemid 32106901)
32. Reddy IK, Aziz W, Sause RB (1996) Artificial tear formulations, irrigating solutions and contact lens products. In: Reddy IK (ed) Ocular therapeutics and drug delivery: a multi-disciplinary approach. Technomic, Lancaster, pp 171-212
33. PKM Kundu M Sinha S Choe D Chattopadhayay 2003 Effect of alcoholic, glycolic, and polyester resin additives on the gelation of dilute solution (1%) of methylcellulose Carbohydr Polym 51 57 61 10.1016/S0144-8617(02)00107-8 1:CAS:528:DC%2BD38Xns1Wkurk%3D
34. Z Jiang J Hao Y You Q Gu W Cao X Deng 2009 Biodegradable thermogelling hydrogel of P(CL-GL)-PEG-P(CL-GL) triblock copolymer: degradation and drug release behavior J Pharm Sci 98 8 2603 2610 10.1002/jps.21613 10.1002/jps.21613 1:CAS:528:DC%2BD1MXns1eqsbo%3D
35. Yin H, Gong C, Shi S, Liu X, Wei Y, Qian Z Toxicity evaluation of biodegradable and thermosensitive PEG-PCL-PEG hydrogel as a potential in situ sustained ophthalmic drug delivery system. J Biomed Mater Res B Appl Biomater 92(1):129-137. doi: 10.1002/jbm.b.31498